| Filed On | Filing |
|---|---|
| 14 Mar 2024 |
Form 4: Thermo Fisher Scientific Inc., 10% owner and 6 others
Disposed of 868,990 shares (Tender Offer) ($5M) |
| 14 Mar 2024 |
Form 4: Thermo Fisher Scientific Inc., 10% owner and 9 others
Disposed of 868,990 shares (Tender Offer) ($5M) |
| 13 Mar 2024 |
Form 4: Faulkner Robert C., Former Director
Disposed of 26,791 shares (Tender Offer) ($154K) · Disposed of 2,068 Stock Options (Right to Buy) (Disposition to Issuer) |
| 13 Mar 2024 |
Form 4: Redmile Group, Llc, Former 10% Owner and Director and 1 other
Disposed of 1,017,203 shares (Tender Offer) ($5.85M) · Disposed of 2,068 Stock Options (Right to Buy) (Disposition to Issuer) · Disposed of 95,765 Earn-Out Right (Disposition to Issuer) |
| 12 Mar 2024 |
Form 4: Shipton Michael, Chief Commercial Officer
Received 8,713 shares by exercise or conversion · Gave up 3,006 shares to cover exercise price or tax ($17.2K) · Disposed of 9,247 shares (Tender Offer) ($53.2K) · 1 more |
| 12 Mar 2024 |
Form 4: Cotliar Jonathan, Chief Medical Officer
Disposed of 41,891 shares (Tender Offer) ($241K) · Returned 12,864 shares to the issuer ($74K) · Disposed of 23,088 Restricted Stock Units (Disposition to Issuer) · 2 more |
| 12 Mar 2024 |
Form 4: Forman Darcy, Chief Delivery Officer
Disposed of 15,753 shares (Tender Offer) ($90.6K) · Returned 24,644 shares to the issuer ($142K) · Disposed of 28,897 Restricted Stock Units (Disposition to Issuer) · 2 more |
| 12 Mar 2024 |
Form 4: Zaranek Mike, Chief Financial Officer
Disposed of 9,070 shares (Tender Offer) ($52.2K) · Returned 22,212 shares to the issuer ($128K) · Disposed of 25,621 Restricted Stock Units (Disposition to Issuer) · 2 more |
| 12 Mar 2024 |
Form 4: Pellizzari Christine A, Chief Legal and HR Officer
Disposed of 14,579 shares (Tender Offer) ($83.8K) · Returned 35,115 shares to the issuer ($202K) · Disposed of 37,222 Restricted Stock Units (Disposition to Issuer) · 1 more |
| 12 Mar 2024 |
Form 4: von Autenried Paul, Former Director
Disposed of 2,302 shares (Tender Offer) ($13.2K) · Disposed of 24,742 Restricted Stock Units (Disposition to Issuer) |
| 12 Mar 2024 |
Form 4: Tiwari Neil, Former Director
Disposed of 2,050 shares (Tender Offer) ($11.8K) · Disposed of 24,742 Restricted Stock Units (Disposition to Issuer) · Disposed of 1,378 Stock Option (Disposition to Issuer) |
| 12 Mar 2024 |
Form 4: Rollins Emily, Former Director
Disposed of 2,050 shares (Tender Offer) ($11.8K) · Disposed of 24,742 Restricted Stock Units (Disposition to Issuer) · Disposed of 1,378 Stock Option (Disposition to Issuer) |
| 12 Mar 2024 |
Form 4: Hubbard John W, Former Director
Disposed of 2,050 shares (Tender Offer) ($11.8K) · Disposed of 24,742 Restricted Stock Units (Disposition to Issuer) · Disposed of 2,540 Earn-Out Right (Disposition to Issuer) · 1 more |
| 12 Mar 2024 |
Form 4: Coman David, Chief Executive Officer
Disposed of 53,834 shares (Tender Offer) ($310K) · Returned 30,781 shares to the issuer ($177K) · Disposed of 49,512 Restricted Stock Units (Disposition to Issuer) · 2 more |
| 10 Oct 2023 |
Form 4: Shipton Michael, Chief Commercial Officer
Received 100,000 shares by exercise or conversion · Gave up 29,201 shares to cover exercise price or tax ($11.9K) |
| 15 Aug 2023 |
Form 4: Coman David, Chief Executive Officer
Received 495,122 shares by exercise or conversion · Gave up 144,576 shares to cover exercise price or tax ($63.6K) |
| 15 Aug 2023 |
Form 4: Forman Darcy, Chief Delivery Officer
Received 288,972 shares by exercise or conversion · Gave up 84,380 shares to cover exercise price or tax ($37.1K) |
| 15 Aug 2023 |
Form 4: Zaranek Mike, Chief Financial Officer
Received 256,207 shares by exercise or conversion · Gave up 74,813 shares to cover exercise price or tax ($32.9K) |
| 15 Aug 2023 |
Form 4: Cotliar Jonathan, Chief Medical Officer
Received 230,882 shares by exercise or conversion · Gave up 79,839 shares to cover exercise price or tax ($35.1K) |
| 15 Aug 2023 |
Form 4: Pellizzari Christine A, Chief Legal and HR Officer
Received 355,549 shares by exercise or conversion · Gave up 86,577 shares to cover exercise price or tax ($38.1K) |
Loading...
